Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1997
Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosisT Koudriavtseva, A J Thompson, M Fiorelli, et al.Neurology|March 4, 1998
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosisC Gasperini, C Pozzilli, S Bastianello, et al.Annals of Neurology|December 1, 1993
A new point mutation of the prion protein gene in Creutzfeldt-Jakob diseaseM Pocchiari, M Salvatore, F Cutruzzolá, et al.European Journal of Neurology|November 28, 2002
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-betaA Paolillo, C Pozzilli, E Giugni, et al.AIDS (London, England)|May 1, 1993
Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complexV Tozzi, P Narciso, S Galgani, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 1999
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted imagesC Gasperini, C Pozzilli, S Bastianello, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1996
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosisC Pozzilli, S Bastianello, T Koudriavtseva, et al.Acta Neurologica Scandinavica|April 1, 1997
The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patientsC Gasperini, C Pozzilli, S Bastianello, et al.Journal of Neuroimmunology|January 15, 2000
Phenotypic and functional properties of gamma delta T cells from patients with Guillain Barré syndromeG Borsellino, F Poccia, R Placido, et al.AIDS (London, England)|October 8, 1999
Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairmentV Tozzi, P Balestra, S Galgani, et al.Pageof 3